Granules Pharmaceuticals

Granules Pharmaceuticals Gets ANDA Approval for Bupropion Hydrochloride Extended-Release Tablets

Feb 03, 2022
Hyderabad: Granules India Limited announced today that the US Food & Drug 
Back to Top